Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

BUY
$44.33 - $57.82 $18,130 - $23,648
409 New
409 $23,000
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $16,470 - $23,308
-409 Closed
0 $0
Q1 2020

Apr 24, 2020

BUY
$25.53 - $70.14 $10,441 - $28,687
409 New
409 $13,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.43B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.